An upper gastrointestinal (UGI) series is radiographic examination of the GI tract for any
abnormalities. It is also known as constant radiography. The global upper GI series market by
Market Research Future takes a look at the various diseases affecting the GI tract,
developments in X-rays, and new projections for the period of 2017 to 2023 (forecast period).
The impact of the COVID-19 pandemic and analysis of its effects as well as the opportunities for
the technology are also discussed in the report.
Request Sample Copy:
The global upper GI series market is expected to grow at a CAGR of 4.5% during the forecast
period. Huge prevalence of GI disorders is one of the primary drivers of the market. The large
healthcare expenditure allocated to detection of GI distress can fuel the market. GI disorders
had accounted for close to USD 110 billion in 2005 in the U.S. alone. The interest of the
pharmaceutical industry as well as large patient pool can be lucrative for the market in the long
Developments in cost-effective treatments, government research for GI disorders, and the large
geriatric populace are other drivers of the market. Effective treatments such as acid
suppressants, histamine H2 receptor antagonists, and proton pump inhibitors are expected to
drive the market to great heights.
But high costs of treatment can impair market growth.
The global upper GI series market is segmented by test type, imaging material, application, and
On the basis of test type, it is divided into standard barium upper GI series and double-contrast
upper GI series.
On the basis of imaging material, the market is segmented into barium swallow, barium follow-
through, and barium meal. The barium swallow segment is likely to fetch huge returns for the
global upper GI series market owing to its ability to detect abnormalities in esophagus,
stomach, and intestines.
On the basis of application, the mar